Connect
MJA
MJA

In the long run, skills are as good as pills for attention deficit hyperactivity disorder

Joseph M Rey
Med J Aust 2008; 188 (3): 133-134.
Published online: 4 February 2008

The need for stimulant treatment must be assessed regularly

In a United States legal action in 2000 about educational neglect, Albany County judge G E Maney ordered the parents to resume administering methylphenidate to 7-year-old Kyle Carroll.1 At the time, this controversial ruling was understandable, because controlled trials of stimulant treatment (dexamphetamine and methylphenidate) for attention deficit hyperactivity disorder (ADHD) had consistently shown that stimulants reduce ADHD symptoms. The catch is that trials have examined short-term effectiveness (usually over less than 6 months), while ADHD is a chronic condition.

  • Joseph M Rey

  • Department of Psychological Medicine, University of Sydney, Sydney, NSW.

Correspondence: jmrey@bigpond.net.au

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.